The Impact of Patent Protection on Health Care in India and the UK. A Comparative Analysis

Inhaltsverzeichnis (Table of Contents)

• INTRODUCTION: PATENTS AND HEALTH CARE
• CHAPTER I: PATENT LAW IN INDIA AND UK
• CHAPTER II: IMPLEMENTATION OF TRIPS FLEXIBILITIES
• CHAPTER III: FRAMEWORKS FOR BALANCING RIGHTS TO ACCESS TO MEDICINES AND INTERESTS OF PHARMACEUTICAL COMPANIES
• RECOMMENDATIONS
• CONCLUSION: SAVING NATIONAL INTEREST?

Zielsetzung und Themenschwerpunkte (Objectives and Key Themes)

This paper provides a comparative analysis of the impact of patent protection on healthcare in India and the UK, focusing on how patent laws influence access to affordable medicines. It aims to understand the implications of TRIPS flexibilities and their implementation in these two countries, considering the balance between incentivizing innovation and ensuring public health.

• Impact of patent protection on healthcare innovation and public health
• Implementation of TRIPS flexibilities in India and the UK
• Balancing access to affordable medicines with the interests of pharmaceutical companies
• Comparative analysis of patent laws in India and the UK
• Role of national health services in access to medicines

Zusammenfassung der Kapitel (Chapter Summaries)

• Chapter I: Patent Law in India and UK: This chapter explores the legal frameworks for patent protection in India and the UK, examining the relevant patent acts and their historical development. It analyzes the strengths and weaknesses of each country's approach to patent law, focusing on the principles underlying patent protection and their impact on innovation and healthcare.
• Chapter II: Implementation of TRIPS Flexibilities: This chapter examines how both countries implement flexibilities within the TRIPS agreement, specifically in the context of patent protection. It discusses the strategies employed by India and the UK to balance their obligations under the agreement with their national interests, focusing on the specific measures adopted to ensure access to affordable medicines.
• Chapter III: Frameworks for Balancing Rights to Access to Medicines and Interests of Pharmaceutical Companies: This chapter delves into the frameworks established in India and the UK to balance the rights of patients to access affordable medicines with the interests of pharmaceutical companies in protecting their intellectual property. It examines the different approaches adopted by the two countries in addressing this complex issue, highlighting the challenges and potential solutions.

Schlüsselwörter (Keywords)

This research focuses on the impact of patent protection on healthcare in India and the UK, examining the role of TRIPS flexibilities, access to affordable medicines, intellectual property rights, pharmaceutical industry, national health services, and comparative analysis of patent laws. It explores the complexities of balancing innovation with public health concerns in the context of developing and developed economies.